Match tier Likely match
Presence Current · Arkansas
Last published 2019
Sources OpenAlex · ORCID
Refreshed 2026-10-08

M. Fox

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Assistant Professor

Also affiliated: University of Maryland, Baltimore (2000); National Institutes of Health (1993–1996); University of Maryland Medical System (2000); National Heart, Lung, and Blood Institute (1996)

3 h-index 12 pubs 762 cited

  • Antineoplastic Combined Chemotherapy Protocols
  • Combined Modality Therapy
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Transduction, Genetic
  • Bone Marrow Transplantation
  • Stem Cell Transplantation
  • Adult
  • Aged
  • Female
  • Male
  • Melphalan
  • Middle Aged
  • Multiple Myeloma
  • Recurrence

Biography and Research Information

Metrics

  • h-index: 3
  • Publications: 12
  • Citations: 762

Positions

  • Assistant Professor publications 2004–2019
    University of Arkansas for Medical Sciences Institution web page

Selected Publications

  • Cellular Immune Function Assay (ImmuKnow) Values during Treatment of Chronic Gvhd Status with Combined Immunosuppressive Drug and Extracorporeal Photopheresis Therapy (2019)
    Transplantation and Cellular Therapy DOI OpenAlex
  • Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma (2006)
    New England Journal of Medicine 742 citations DOI OpenAlex
  • Low Frequency of Treatment-Related Myelodysplastic Syndromes (t-MDS) after Autotransplants (AT) for Multiple Myeloma (MM), Especially If AT Is Applied Early during Treatment. (2005)
    Blood 2 citations DOI OpenAlex
  • Complete Response (CR) with Total Therapy 2 (TT2) for Multiple Myeloma (MM): Low Frequency in Case of Prior MGUS without Adverse Consequences for Survival - Yet Critical for Disease Control in Presumed “De Novo” MM. (2005)
    Blood 1 citation DOI OpenAlex
  • High-dose treatment (HDT) and autologous stem cell transplant (ASCT) in Waldenstrom’s macroglobulinemia (WM) patients (pts): A single center experience (2005)
    Journal of Clinical Oncology 2 citations DOI OpenAlex
  • Successful mobilization of peripheral blood stem cells (PBSCs) with AMD3100 in patients failing to collect with hematopoietic growth factors (HGF) and/or chemotherapy (2004)
    Journal of Clinical Oncology DOI OpenAlex
  • NY-ESO-1 Specific Antibodies Are Frequently Detected in Hight-Risk Myeloma. (2004)
    Blood DOI OpenAlex
  • Successful mobilization of peripheral blood stem cells (PBSCs) with AMD3100 in patients failing to collect with hematopoietic growth factors (HGF) and/or chemotherapy (2004)
    Journal of Clinical Oncology 3 citations DOI OpenAlex

View all publications on OpenAlex →